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Background: It is unclear if the sugar intake may affect metabolic parameters in individuals with type 1 diabetes.
Therefore, the purpose of this study was to evaluate the effects of sucrose intake in glycemic, lipemic,
anthropometric variables, as well as in C-reactive protein (CRP) levels in these individuals.
Methods: Thirty-three subjects with type 1 diabetes were evaluated at baseline and 3-months after intervention.
Volunteers were randomized into groups: sucrose-free (diet without sucrose) or sucrose-added (foods containing sucrose
in composition). Both groups received the same macronutrient composition and used the carbohydrate counting
methods. All underwent an interview and anthropometric evaluation. Blood was drawn for glycated haemoglobin,
glucose, total cholesterol, HDL, and CRP measurement, and the medical charts were reviewed in all cases.
Results: At baseline, anthropometric, clinical and laboratory variables did not differ between groups, except for the
triglycerides. Although at baseline triglycerides levels were higher in the sucrose-added group (p = 0.01), they did not
differ between groups after the intervention (p = 0.92). After 3-months, CRP was higher in the sucrose-added than in the
sucrose-free group (p = 0.04), but no further differences were found between the groups, including the insulin
requirements, anthropometric variables, body composition, and glycemic control. Both groups showed sugars intake
above the recommendations at baseline and after intervention.
Conclusions: Sucrose intake, along with a disciplined diet, did not affect insulin requirements, anthropometric variables,
body composition, lipemic and glycemic control. However, although the sucrose intakes increase CRP levels, the amount
of sugar in the diet was not associated with this inflammatory marker.
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Sucrose is a very attractive source of carbohydrate [1]. The
preference for sucrose may be influenced by genetic factors
[2-5], and others complex behaviors (such as craving, in-
fant exposure, social habits, and personal dietary choices)
[6-10]. The effect of sugars on lipid metabolism remains an
extremely active area of inquiry because has been shown* Correspondence: deboralopessouto@gmail.com
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reproduction in any medium, provided the orthat high-sugar diets may increase triglycerides levels in
subjects with type 2 diabetes [11-13], but they do not seem
to affect the lipid profile in subjects with type 1 diabetes, if
optimal glycemic control is preserved [14-18].
Carbohydrate is the major determinant of postprandial
glucose levels. The carbohydrate counting is the best
method for estimating the grams of carbohydrates in a
meal and then calculating the pre-meal insulin dose
based on the self-monitored blood glucose (SMBG) and
insulin-to-carbohydrate ratio [1,19].
The American Diabetes Association nutrition recom-
mendations state that the meal plans based on carbohy-
drate counting remains a key strategy to achieve the
glycemic control [1] because the adjustment of pre-prandial
insulin doses to the amounts of dietary carbohydratestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in glycemic control [20-24], self-management skills, quality
of life, and dietary freedom [25-29].
However, the basic and advanced carbohydrate count-
ing are the common methods used currently in clinical
practice [19,22,30]. In the basic method, the subjects are
encouraged to eat constant amounts of carbohydrate at
meals. This is useful to understand the effect of food, in-
sulin and to identify the portion sizes, considering that
one carbohydrate serving have an approximately 15 g of
carbohydrates (these information are obtained from ex-
change lists, internet and from the nutrition facts). In
the advanced method, the patients should have a good
understanding of carbohydrate counting principles, as
well as understanding pattern management and how to
use insulin-to-carbohydrate ratios [1,19,30]. According
to described, the inclusion of sucrose in the dietary plan
of individuals with type 1 diabetes is quite appealing and
has been a focus of interest, especially after the introduc-
tion of the carbohydrate counting methods. However,
previous studies suggested that sugar intake may active
inflammation pathways and increase circulatory levels of
the inflammatory markers, such as C-reactive protein
(CRP) both in health individuals [31-33] and patients
with type 2 diabetes [34]. However, clinical trials in type
1 diabetes are still lacking.
The goal of this study was to investigate the influence of
sucrose intake on anthropometric variables, body compos-
ition, lipemia, glycemic control and CRP levels in subjects
with type 1 diabetes.Subjects and methods
This is a controlled clinical-trial was conducted between
July 2009, and January 2011. Participants with type 1 dia-
betes (disease duration of 24 years or more) were recruited
at the waiting room of the Clementino Fraga Filho Univer-
sity Hospital, Brazil. Patients with body mass index (BMI) ≥
30 kg/m2, smokers, alcoholics, users of lipid-lowering or
oral hypoglycemic medications and other diseases (such as
hypertension, celiac disease, hypo- and hyperthyroidism)
were not included.
The hospital database update on January 2010, the size
of the universe is 200 outpatients. Of these, only 80 (40%)
of these cases were eligible and were then contacted and in-
vited to participate. Forty-five (22%) refused and 35 (17.5%)
volunteers agreed to participate in the study. All signed an
informed consent and the protocol was approved by the
Ethical Committee (Institutional Review Board, protocol
050/09). During the follow-up, two patients were excluded
(one had infection and another because did not use in-
sulin properly) and a total of 33 (16.5%) participants
completed the study. The sample is not representative
and was selected for convenience, thus, results are notintended to represent exactly what would happen with a
population [35].
All volunteers were assessed at baseline and after 3-
months of intervention. They received three individual
face-to-face consultation sessions which included advices
on food purchased, food selection, portion sizes, cooking
methods, and effect of food on glycemic control.
Participants were allocated into two groups, according
to their sucrose intake reported in three 24-hour recalls.
Individualized diet prescription based on the current
recommendations (dietary energy content of 50-60% car-
bohydrates, 15-20% of protein, 25-35% of total fat, less
than 7% of saturated fatty acids, a maximum of 10% 10%
from polyunsaturated fatty acids, and 10-15% of mono-
unsaturated fatty acids) [1].
Percent energy from macronutrients was similar in both
groups [1,36] and as well as the same instructions about
carbohydrate counting, and exchange lists with sucrose-
free or with foods containing sucrose in its compositions
(for sucrose-added group). The lists have been developed
based on “Choose your foods: Exchange lists for diabetes”
[37] and contained more than 200 foods with a similar
amount of carbohydrates (approximately 15 g of carbohy-
drates per serving), however we detailed listings in the
catalogues of permitted and prohibited foods, based on
the amount of sugar in each product were also provided
to the participants. Diets and dietary records were ana-
lyzed using Software DietPró 5.5i (version 2008–2011)
and the cutoff point for sucrose intake was < 7 or ≥ 7% to
sucrose-free and sucrose-added group, respectively.
The carbohydrate counting method was selected as ac-
cording to ability to the patient’s understand the man-
agement plan and how to use insulin-to-carbohydrate
ratios properly [1,19]. The basic and advanced carbohy-
drate counting were equally distributed between groups
(p = 0.62). Basic method was used for 50% (n = 9) in
sucrose-free and 53.33% (n = 8) in sucrose-added group,
and the advanced method was used for 50 and 46.67%
(n = 9 for each) of volunteers in sucrose-free and sucrose-
added group, respectively.
Baseline dietary intake was evaluated from 3-day diet re-
cords. Volunteers were followed monthly when 24-hour
recalls were performed to verify adherence to the diet.
Additionally, they were followed once a week by telephone
calls [38].
Insulin, glucometer and test strips to check their SMBG
four-daily were provided to all participants. The insulin sen-
sitivity factor was calculated as 1800 or 1500 (for rapid in-
sulin analogs and regular insulin, respectively) divided by
the total daily insulin dose. Insulin-to-carbohydrate ratios
were calculated as 500 or 450 divided by the total daily
insulin dose (for rapid insulin analogs and regular insulin,
respectively) and frequently were adjusted 2-hour postpran-
dial. Patients were instructed to calculate their premeal
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alized insulin-to-carbohydrate ratios, and theirs SMBG [39].
Blood sample were obtained after eight hours fasting,
and events that could influence the results were considered
(such as: infections, flu, fever). Glycated haemoglobin was
performed by high-performance liquid chromatography
[40]. Fasting glucose, total cholesterol, HDL and triglycer-
ides were measured by enzymatic colorimetric method,
and CRP was determined by ultrasensitive colorimetric
enzyme-linked immunosorbent assay [41]. LDL cholesterol
was calculated with the Friedewald equation [42].
Body mass index was calculated as body weight in ki-
lograms divided by the square of height in meters [43].
Waist circumference was determined as the average of
two measurements calculated to the nearest 0.1 cm mid-
way between the lower rib margin and the iliac crest after
a normal expiration [44]. Body composition was measured
by tetrapolar bioelectrical impedance (biodynamic Model
450) [45].
Statistical analyzes were performed in SPSS software
(version 16.0; SPSS Inc, Chicago, IL) with significance
level of 5%. Quantitative variables were described as the
mean and standard deviation. Mann–Whitney test was
used for between-group comparison and Wilcoxon test
to compare the effects of nutrition-knowledge in each
group. Linear regression was used to determine the value
of the triglycerides and CRP levels based upon the values
of other variables.Results
Thirty three patients with type 1 diabetes (21 men and
12 women) with a mean age of 21.7 ± 5 years old (range,
15 to 37) and mean duration of disease of 11.9 ± 6.4 years
(range, 2 to 18) were included (Table 1). All were in a
basal-bolus plan, 32 using multiple daily injections and
one in insulin-pump.Table 1 Anthropometric characteristics at baseline and after
Baseline
Sucrose-free Sucrose-added p value‡ Sucr
(n = 18) (n = 15) (n
M/F (n) 12/6 8/7 0.53
BMI (kg/m2) 22.40 ± 2.65 24.02 ± 2.56 0.07 22.8
WC (cm) 76.50 ± 7.78 76.60 ± 7.70 0.85 76.2
Body fat (%) 18.57 ± 7.05 23.64 ± 8.76 0.05 18.8
LBM (%) 81.44 ± 7.05 76.34 ± 8.77 0.05 81.1
TBW (%) 38.29 ± 6.50 37.50 ± 8.97 0.60 38.5
♦Data are mean ± SD.
‡p-values were derived by Mann–Whitney test.
║p-values were derived by analysis of covariance with basal and values during the n
#p values were derived by analysis of covariance with basal and values during and
rank test).
Legend/abbreviations: BMI Body mass index, LBM Lean body mass, M/F Male/femaleTen patients used the carbohydrate counting method
prior to the study (30%), and this proportion did not dif-
fer between groups (p = 0.33).
Anthropometric, biochemical and clinical basal charac-
teristics were similar between groups, except for the tri-
glycerides levels, that were higher in the sucrose-added
group (p = 0.01) (Tables 1 and 2). Nevertheless, regression
analysis showed no association between triglycerides and
other variables (p > 0.05).
Anthropometric variables were not associated with in-
sulin sensitivity factor, total daily insulin dose or insulin-
to-carbohydrate ratio (p > 0.05).
Both groups had a hypocaloric, hyperprotein, normogly-
cidic, normolipidic and an adequate fiber intake, when
compared with the American Diabetes Association [1]
and Dietary Reference Intakes [36] current recommenda-
tions. There were no differences between groups in these
parameters. Sucrose (p = 0.01) and saturated fatty acids
(p = 0.03) intake were higher in the sucrose-added than in
the sucrose-free group, however, both groups showed sim-
ple carbohydrate and saturated fatty acids intakes above
the daily recommended intake based on the current
guidelines [1,36] (Table 3).Characteristics of groups after intervention
During the intervention, both groups remained in a
hypocaloric, hyperprotein, normoglycidic, normolipidic
and adequate fiber diet [1,36]. The sucrose-added group
continued to show a higher sucrose intake than sucrose-
free group (p < 0.01), however both groups presented
simple carbohydrate intake below the recommendations
[1,36]. The monounsaturated fatty acids intake was
higher in the sucrose-added group, when compared to
the sucrose-free group (p < 0.01), but both groups pre-
sented intakes below the recommendations [1,36]. The
other nutrients did not differ between groups (Table 3).intervention in sucrose-free and sucrose-added groups♦
After intervention p value║ p value#
ose-free Sucrose-added p value‡
= 18) (n = 15)
12/6 8/7 0.53 - -
4 ± 2.51 23.89 ± 2.39 0.19 0.23 0.34
2 ± 7.83 76.40 ± 7.16 0.92 0.51 0.48
1 ± 6.94 22.94 ± 9.51 0.14 0.64 0.47
8 ± 6.94 76.72 ± 9.14 0.07 0.73 0.52
2 ± 5.62 38.44 ± 9.01 0.53 0.39 0.18
utritional intervention in sucrose-free group (Wilcoxon signed rank test).
after the nutritional intervention in sucrose-added group (Wilcoxon signed
, TBW Total body water, WC Waist circumference.
Table 2 Biochemical and clinical characteristics at baseline and after intervention in sucrose-free and
sucrose-added groups♦
Baseline After intervention p value║ p value#
Sucrose-free Sucrose-added p value‡ Sucrose-free Sucrose-added p value‡
(n = 18) (n = 15) (n = 18) (n = 15)
Glucose (mmol/L) 9.42 ± 3.86 10.86 ± 3.61 0.25 9.46 ± 4.18 8.63 ± 5.1 0.40 0.87 0.24
HbA1c (%) 7.33 ± 1.06 8.02 ± 2.14 0.57 7.28 ± 0.91 7.76 ± 1.53 0.65 0.67 0.67
TC (mmol/L) 8.59 ± 1.84 9.36 ± 2.44 0.32 8.70 ± 1.89 9.61 ± 3.22 0.42 0.98 0.69
HDL (mmol/L) 2.72 ± 0.65 2.92 ± 0.78 0.32 2.67 ± 0.60 2.94 ± 0.78 0.23 0.37 0.75
LDL (mmol/L) 4.77 ± 1.40 5.14 ± 1.80 0.46 4.69 ± 1.53 5.27 ± 2.10 0.34 0.44 0.84
TG (mmol/L) 3.48 ± 1.43 5.36 ± 2.33 0.01 4.18 ± 1.44 5.65 ± 4.58 0.92 0.06 0.79
CRP (mmol/L) 0.27 ± 0.20 0.38 ± 0.20 0.17 0.29 ± 0.13 0.42 ± 0.24 0.04 0.79 0.94
TBD (UI/kg/d) 0.69 ± 0.17 0.61 ± 0.19 0.19 0.68 ± 0.16 0.61 ± 0.19 0.27 1.00 1.00
ICR 14.45 ± 5.12 11.84 ± 1.88 0.11 14.45 ± 5.12 11.84 ± 1.88 0.11 1.00 1.00
CF 35.88 ± 7.12 40.00 ± 8.45 0.10 35.88 ± 7.12 40.00 ± 8.45 0.10 1.00 1.00
SMBG (mmol/L) 8.32 ± 1.43 9.02 ± 1.91 0.31 8.32 ± 1.43 9.02 ± 1.91 0.31 1.00 1.00
MDI (times/day) 3.70 ± 0.84 3.73 ± 0.70 0.79 3.70 ± 0.84 3.73 ± 0.70 0.79 1.00 1.00
♦Data are mean ± SD.
‡p-values were derived by Mann–Whitney test.
║p-values were derived by analysis of covariance with basal and values during the nutritional intervention in sucrose-free group (Wilcoxon signed rank test).
#p values were derived by analysis of covariance with basal and values during and after the nutritional intervention in sucrose-added group (Wilcoxon signed
rank test).
Legend/abbreviations: CF Correction factor, CRP C-reactive protein, HbA1c Glycosylated hemoglobin, ICR Insulin-to-carbohydrate ratio, MDI Multiple daily injections
using fast-acting insulin, SMBG Self-monitored blood glucose, TBD Total basal dose, TC total cholesterol, TG triglycerides.
Souto et al. Diabetology & Metabolic Syndrome 2013, 5:67 Page 4 of 8
http://www.dmsjournal.com/content/5/1/67Comparing the intake before and after intervention,
the sucrose-free group increased the sucrose, polyunsat-
urated and monounsaturated fatty acids intake, however
reduced the energy and fiber intake (p < 0.05). The Sucrose-
added group reduced energy, carbohydrate and fiber, while
increased fat intake (p < 0.05) (Table 3).Table 3 Recommended dietary allowance and actual dietary i
and sucrose-added groups♦
Baseline
Sucrose-free Sucrose-added p valu
(n = 18) (n = 15)
Recommended dietary
allowance (kcal)
2589.66 ± 441.01 2539.90 ± 370.38 0.60
Energy (kcal) 2117.29 ± 454.99 2158.58 ± 504.65 0.66
Carbohydrate (%) 51.32 ± 6.90 50.27 ± 6.07 0.80
Sucrose (%) 5.29 ± 6.59 17.21 ± 14.12 0.01
Fructose (%) 6.66 ± 5.98 7.78 ± 7.51 0.77
Protein (%) 18.38 ± 2.68 19.25 ± 3.15 0.56
Fat (%) 29.43 ± 6.78 30.14 ± 7.24 0.85
Saturated fatty acids (%) 9.25 ± 3.62 11.44 ± 4.24 0.03
Polyunsaturated fatty acids (%) 5.89 ± 3.45 5.18 ± 2.80 0.36
Monounsaturated fatty acids (%) 7.78 ± 2.99 7.40 ± 1.84 0.75
Fiber intake (g) 24.77 ± 8.11 25.86 ± 13.78 0.82
♦Data are mean ± SD; ‡p-values were derived by Mann–Whitney test.
║p-values were derived by analysis of covariance with basal and values during the n
#p values were derived by analysis of covariance with basal and values during and afteThe data included an average of 111 ± 15.57 SMBG
per month for each participant. Insulin requirements,
anthropometric and laboratory variables did not differ
after the intervention, in any of the groups. The sucrose-
added group presented higher CRP concentrations than
others volunteers (p = 0.04), although other variables didntake at baseline and after intervention in sucrose-free
After intervention p value║ p value#
e‡ Sucrose-free Sucrose-added p value‡
(n = 18) (n = 15)
2589.66 ± 441.01 2539.90 ± 370.38 0.60 - -
2332.93 ± 309.20 2367.71 ± 426.28 0.40 0.01 0.02
53.19 ± 5.89 58.42 ± 4.57 0.57 0.28 0.00
2.34 ± 1.16 27.32 ± 13.47 0.00 0.03 0.06
5.98 ± 4.14 9.43 ± 7.85 0.31 0.68 0.30
19.80 ± 2.53 19.88 ± 3.37 0.89 0.12 0.17
24.22 ± 7.96 25.66 ± 4.53 0.49 0.07 0.03
8.67 ± 3.38 9.93 ± 3.63 0.38 0.81 0.10
3.66 ± 2.30 4.13 ± 1.48 0.12 0.00 0.21
4.25 ± 2.52 6.60 ± 1.49 0.00 0.00 0.15
37.48 ± 13.08 34.44 ± 13.99 0.69 0.00 0.02
utritional intervention in sucrose-free group (Wilcoxon signed rank test).
r the nutritional intervention in sucrose-added group (Wilcoxon signed rank test).
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ated with any of the anthropometric or laboratory vari-
ables (p > 0.05). Regression analysis showed no association
between the amount of sucrose intake and CRP levels in
any of the groups (p > 0.05) (Table 2).
Triglycerides showed a positively association with the
mean of SMBG levels (r = 0.71; p = 0.00) only in the
sucrose-added group, however, did not differ between
groups after intervention (p = 0.92), as opposed to base-
line (p = 0.01). There was a trend towards an increase in
triglycerides levels in the sucrose-free group (p = 0.06),
which was not observed in the sucrose-added group (p =
0.79) (Table 2). However, the amount of sucrose intake was
positively associated to triglyceride levels (r = 0.52; p = 0.04).
Discussion
In this study we showed that the sugar intake did not
affect the anthropometric variables, body composition and
glycemic control after 3-months in subjects with type 1
diabetes. This was the first clinical trial to assess the influ-
ence of sucrose in these variables in individuals with type
1 diabetes and showed a link between sucrose intake and
increase of CRP. Studies have reported that CRP levels are
higher in subjects with type 1 [46] and type 2 diabetes [47]
compared with those without diabetes, while another
study not find any correlation between CRP levels and
titer of autoantibodies in long-term type 1 individuals with
type 1 diabetes [48].
Previous studies have shown positive correlation between
sugar intake and CRP in rats [49,50], healthy adults [51-54],
children [55], obese [32,56], and individuals with type 2 dia-
betes [57-59], suggesting several possible mechanisms. One
explanation would be the stimulation of the inflammatory
response as a consequence of hyperglycemia [53,57,60]. An-
other mechanism could be an effect of glucose and fructose
in enzymatic pathways and in the transcription factors
involved in lipogenesis. This could lead to peroxisome pro-
liferation changes, microsomal enzyme induction, and tran-
scription of inflammatory factors by the activating nuclear
factor-κB [61-63]. Alternatively, our third hypothesis is that
the chronic hyperglycemia combined with sugar intake
could induced release of the neuropeptide Y (a sympathetic
neurotransmitter) directly into the adipose tissue, which
stimulates endothelial cell (angiogenesis), and consequently
leads to increase cytokines and acute phase proteins [64].
There are other hypotheses to explain why high sugars
intake could lead to an increase in the levels of inflamma-
tory markers. However, these mechanisms have been ob-
served in mice [61,62], healthy [53,63], obese [63,65] or
individuals with type 2 [57,63]. To our knowledge, this
was the first study to examine the effect of sucrose intake
in the CRP levels in the subjects with type 1 diabetes.
Even though the between-group differences in CRP in
the present study were small, and CRP has been used asa consistent marker for evaluating the extent of cardiovas-
cular diseases in subjects with type 1 diabetes [66-70], we
suggest that others determinants, such as genetic predis-
position, coping mechanisms, and environmental factors,
make individuals more susceptible to changes in this in-
flammatory marker. Therefore, further studies are neces-
sary to understand the effect of sugar intake in CRP levels.
In addition, we showed that triglycerides levels did not
differ between groups after intervention, in contrast to
baseline, suggesting a trend toward an increased in tri-
glycerides levels in sucrose-free group. Although, the
increase in triglyceride levels was not statistically signifi-
cant, a possible reason for this worsening might be the
reduced fiber intake [71,72].
Furthermore, the scarcity of controlled studies asses-
sing the effect of sucrose intake on metabolic control in
well controlled subjects with type 1 diabetes difficult the
comparison with other studies. Controlled studies asses-
sing the effect of sucrose in metabolic control of individ-
uals with type 1 diabetes are still lacking because the
studies have used fructose as sugar source [73-75] or
high-glycemic index diet [15,76,77]. Only one observational
study reported an association between sugar-sweetened
beverages and high triglycerides levels in subjects with type
1 diabetes [78], while a controlled trial showed no effect of
foods with sucrose on triglycerides levels in this population
[18]. Therefore, although our data suggests that the sucrose
intake did not change triglycerides levels, further larger and
longer studies are still necessary to elucidate this finding.
Furthermore, in this study, triglycerides had no rela-
tionship with CRP. This finding is opposite to other
studies, which suggest that strategies to decrease inflam-
matory activity in type 1 diabetes should focus on the
triglycerides levels [79]. Corroborating previous studies
that have associated the glycemic control with triglycer-
ides, we observed a positively association between triglyc-
erides and SMBG, demonstrating the glycemic control is
an important mediator of lipid abnormalities [16,17,80].
This may occur because the insulin influences the activity
of lipase lipoprotein and inhibits the lipolysis of fats stored
in the tissues by inhibition of hormone-sensitive lipase.
Thus, such as endogenous insulin, the effective insulin
treatments influence the lipid transfers in well-controlled
patients with type 1 diabetes [16].
There are potential limitations regarding the interpret-
ation of our data. Firstly, two characteristic (triglycerides
levels and saturated fatty acids intake) differed between
groups at baseline. In addition, the sucrose intake was
not the only dietary factor that differed between groups
during the intervention (sucrose-added group presented
a higher monounsaturated fatty acids intake than the
sucrose-free group). Interestingly, both groups had fatty
acids intakes above the current recommendations, based
on the American Diabetes Association guidelines [1].
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cause the sample was selected by convenience [35]. Fur-
thermore, the adherence to the prescribed diet is difficult
to accomplish [81-84]. Thus, these results could not rep-
resent what would happen with the entire population [35].
In summary, although American Diabetes Association
report that “unnecessarily restrict sucrose” [1] and all our
subjects (both groups) had less than 10% of energy from
sugars, we showed that intake of sucrose did not alter
body weight, body composition, glycemic and lipemic
control, however, there is a link between sucrose intake
and increase of CRP. For this reason, according to the
above result, we suggest that individuals with diabetes
choose to avoid high-sucrose foods even they may eat a
relatively small amount. Therefore, further clinical stud-
ies are needed to assess the relationship between sugars
and CRP levels in subjects with type 1 diabetes.
Conclusions
Sucrose intake, along with a disciplined diet, compared
with sucrose-free diet, did not affect insulin requirements,
anthropometric variables, body composition, glycemic, and
lipemic control. However, although the sucrose intakes in-
crease CRP levels, the amount of sugar in the diet was not
associated with this inflammatory marker.
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